This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by van de Wal, R. M. Articles by Voors, A. A Search for Related Content PubMed PubMed Citation Articles by van de Wal, R. M. Articles by Voors, A. A Social Bookmarking                         What's this?

Plasma matrix metalloproteinase-9 and ACE-inhibitor-induced improvement of urinary albumin excretion in non-diabetic, microalbuminuric subjects

St Antonius Hospital, Department of Cardiology, Koekoekslaan 1, 3435 CM, Nieuwegein, The Netherlands

Pim van der Harst

University Medical Center Groningen, University of Groningen, Department of Cardiology, Hanzeplein 1, 9700 RB, Groningen, The Netherlands, University Medical Center Groningen, University of Groningen, Department of Experimental Cardiology, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands

Wim BM Gerritsen

St Antonius Hospital, Department of Clinical Chemistry, Koekoekslaan 1, 3435 CM, Nieuwegein, The Netherlands

Fal van der Horst

St Antonius Hospital, Department of Clinical Chemistry, Koekoekslaan 1, 3435 CM, Nieuwegein, The Netherlands

Thijs HW Plokker

St Antonius Hospital, Department of Cardiology, Koekoekslaan 1, 3435 CM, Nieuwegein, The Netherlands

Ron T Gansevoort

University Medical Center Groningen, University of Groningen, Department of Internal Medicine, Hanzeplein 1, 9700 RB, Groningen, The Netherlands

Wiek H van Gilst

University Medical Center Groningen, University of Groningen, Department of Experimental Cardiology, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands

Adriaan A Voors

University Medical Center Groningen, University of Groningen, Department of Cardiology, Hanzeplein 1, 9700 RB, Groningen, The Netherlands, a.a.voors{at}thorax.umcg.nl

Introduction. Elevated plasma matrix metalloproteinase-9 (MMP-9) levels have been suggested to precede the development of microalbuminuria. As angiotensin-converting enzyme (ACE) inhibitors effectively reduce urinary albumin excretion (UAE), in the present study we have investigated the potential association of plasma MMP-9 levels with UAE and treatment effects of ACE-inhibition. Material and methods. In a placebo-controlled

randomised trial we determined plasma MMP-9 levels at baseline and after three months of randomisation to either placebo (n=202) or fosinopril (20 mg/day, n=204) treatment.

Results. Baseline plasma MMP-9 levels were not related to baseline UAE (r=-0.008, p=0.871).Three months of fosinopril treatment effectively reduced UAE compared to placebo treatment (-10.4±2.4 vs. 1.8±1.3 mg/24 hours, p<0.001, respectively). However, fosinopril treatment failed to significantly change plasma MMP-9 levels compared to placebo (-0.47±7.68 vs. 0.06±9.20, p=0.646, respectively) . In addition, the change in UAE was not related with change in MMP-9 levels.

Conclusion. The effective reduction of UAE with fosinopril was not related to plasma MMP-9 levels.

Key Words: angiotensin-converting enzyme • ACE-inhibitors • fosinopril matrix metalloproteinase-9 • urinary albumin excretion

References

• Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., Jensen T., Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989;32:219-26.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Yuyun MF, Khaw KT, Luben R. et al. A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population: the EPIC-Norfolk study. Am J Epidemiol 2004;159:284-93.[Abstract/Free Full Text]
• Hillege HL, Fidler V., Diercks GF et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002;106:1777-82.[Abstract/Free Full Text]
• Gerstein HC, Mann JF, Yi Q. et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-6.[Abstract/Free Full Text]
• Bigazzi R., Bianchi S., Baldari D., Campese VM Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 1998;16:1325-33.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Jensen JS, Feldt-Rasmussen B., Borch-Johnsen K., Clausen P., Appleyard M., Jensen G. Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals. J Hum Hypertens 1997;11:727-32.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Allen KV, Walker JD Microalbuminuria and mortality in long-duration type 1 diabetes. Diabetes Care 2003;26:2389-91.[Abstract/Free Full Text]
• Romundstad S., Holmen J., Kvenild K., Hallan H., Ellekjaer H. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: A 4.4-year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis 2003;42:466-73.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Borch-Johnsen K., Feldt-Rasmussen B., Strandgaard S., Schroll M., Jensen JS Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999;19:1992-7.[Abstract/Free Full Text]
• Kannel WB, Stampfer MJ, Castelli WP, Verter J. The prognostic significance of proteinuria: the Framingham study. Am Heart J 1984;108:1347-52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Asselbergs FW, Diercks GF, Hillege HL et al. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 2004;110:2809-16.[Abstract/Free Full Text]
• Parving HH, Hommel E., Smidt UM Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ 1988;297:1086-91.[Abstract/Free Full Text]
• Ravid M., Savin H., Jutrin I., Bental T., Katz B., Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993;118:577-81. 14. Effects of ramipril on cardiovascular and microvascular
• outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000;355:253-9. 15. Ruggenenti P, Fassi A, Ilieva AP et al. Preventing[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• microalbuminuria in type 2 diabetes. N Engl J O Med 2004;351:1941-51.[CrossRef]
• Viberti G., Mogensen CE, Groop LC, Pauls JF Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA 1994;271:275-9. converting enzyme inhibitors and progression of nondiabetic[Abstract/Free Full Text]
• Jafar TH, Schmid CH, Landa M. et al. Angiotensinconverting progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 2001;135:73-87.[Abstract/Free Full Text]
• Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet 1997;349:1857-63.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• van de Wal RM, Gansevoort RT, van der Harst P. et al. Predictors of Angiotensin-Converting Enzyme Inhibitor-Induced Reduction of Urinary Albumin Excretion in Nondiabetic Patients. Hypertension 2006;48:870-6.[Abstract/Free Full Text]
• van de Wal RM, Plokker HW, Lok DJ et al. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. Int J Cardiol 2006;106:367-72.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Tsilibary EC Microvascular basement membranes in diabetes mellitus. J Pathol 2003;200:537-46.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ebihara I., Nakamura T., Shimada N., Koide H. Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1998;32:544-50.[Web of Science][Medline] [Order article via Infotrieve]
• Diercks GF, Janssen WM, van Boven AJ et al. Rationale, design M,and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT]). Am J Cardiol 2000;86:635-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sundstrom J., Evans JC, Benjamin EJ et al. Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study. Circulation 2004;109:2850-6.[Abstract/Free Full Text]
• Boffa JJ, Lu Y., Placier S., Stefanski A., Dussaule JC, Chatziantoniou C. Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol 2003;14:1132-44.[Abstract/Free Full Text]
• Tashiro K., Koyanagi I., Ohara I. et al. Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal 2004;18:206-10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 8, No. 4, 177-180 (2007)
DOI: 10.3317/jraas.2007.029


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by van de Wal, R. M. Articles by Voors, A. A Search for Related Content PubMed PubMed Citation Articles by van de Wal, R. M. Articles by Voors, A. A Social Bookmarking                         What's this?